Sequent Scientific Ltd

Sequent Scien. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sequent Scientific Ltd

₹ 117 0.30%
18 May - close price
sequent.in BSE: 512529 NSE: SEQUENT
About

Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.

Key Points

Business segment & Revenue Mix FY22
The company has 2 business segments: Formulation and API. [1]

Website BSE NSE
  • Market Cap ₹ 2,907 Cr.
  • Current Price ₹ 117
  • High / Low ₹ 156 / 70.2
  • Stock P/E
  • Book Value ₹ 26.3
  • Dividend Yield 0.00 %
  • ROCE 0.90 %
  • ROE -2.46 %
  • Face Value ₹ 2.00
Edit ratios

Pros

Cons

  • Stock is trading at 4.43 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 5.68% over past five years.
  • Company has a low return on equity of -1.84% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
361.82 320.51 350.55 358.05 383.71 341.32 337.61 375.31 366.67 333.21 345.97 329.36 361.20
318.54 300.36 330.88 321.83 350.36 339.20 334.74 364.96 370.04 341.45 330.84 307.11 328.93
Operating Profit 43.28 20.15 19.67 36.22 33.35 2.12 2.87 10.35 -3.37 -8.24 15.13 22.25 32.27
OPM % 11.96% 6.29% 5.61% 10.12% 8.69% 0.62% 0.85% 2.76% -0.92% -2.47% 4.37% 6.76% 8.93%
1.59 2.67 0.74 3.67 3.77 -2.32 0.91 2.86 -59.86 -22.72 9.72 7.28 -0.71
Interest 3.18 3.02 3.26 3.45 6.04 6.80 8.12 9.73 10.87 10.48 12.58 12.58 12.44
Depreciation 12.68 12.57 13.21 12.83 12.93 13.93 13.38 13.67 14.71 14.24 15.36 15.46 16.48
Profit before tax 29.01 7.23 3.94 23.61 18.15 -20.93 -17.72 -10.19 -88.81 -55.68 -3.09 1.49 2.64
Tax % 18.89% 63.35% -250.51% 21.39% 45.45% 26.85% 74.94% 4.12% -4.10% 37.72% -122.65% -616.78% 51.52%
23.52 2.65 13.82 18.56 9.90 -15.32 -4.44 -9.78 -92.44 -34.68 -6.88 10.68 1.28
EPS in Rs 0.83 0.04 0.58 0.69 0.36 -0.60 -0.15 -0.36 -3.75 -1.40 -0.34 0.33 -0.04
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
327 395 443 606 684 848 1,039 1,179 1,362 1,413 1,421 1,370
340 389 425 550 641 765 914 1,009 1,150 1,303 1,409 1,308
Operating Profit -13 6 18 56 43 83 125 170 212 109 12 61
OPM % -4% 2% 4% 9% 6% 10% 12% 14% 16% 8% 1% 4%
3 -54 48 14 9 436 9 10 -0 11 -58 -6
Interest 33 34 43 38 28 33 33 36 24 16 36 48
Depreciation 29 29 32 46 40 41 42 51 51 52 56 62
Profit before tax -73 -110 -8 -14 -17 444 59 94 137 53 -138 -55
Tax % 11% -1% -40% -19% 3% 3% 3% 13% 24% 15% 11% 46%
-65 -110 -12 -16 -16 431 57 82 104 45 -122 -30
EPS in Rs -5.39 -8.09 -0.70 -0.78 -0.57 17.30 1.97 2.81 3.84 1.65 -4.86 -1.44
Dividend Payout % -0% -0% -0% -0% -0% 1% 10% -0% 13% -0% -0% -0%
Compounded Sales Growth
10 Years: 13%
5 Years: 6%
3 Years: 0%
TTM: -4%
Compounded Profit Growth
10 Years: 5%
5 Years: %
3 Years: %
TTM: 73%
Stock Price CAGR
10 Years: 10%
5 Years: 11%
3 Years: -25%
1 Year: 49%
Return on Equity
10 Years: 9%
5 Years: 4%
3 Years: -2%
Last Year: -2%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 23 27 30 48 49 49 49 50 50 50 50 50
Reserves 60 19 32 885 928 599 657 637 678 642 649 607
311 418 473 312 416 305 325 343 277 365 444 488
192 159 372 278 503 380 346 424 381 378 374 396
Total Liabilities 586 623 908 1,523 1,896 1,332 1,378 1,454 1,386 1,435 1,517 1,540
227 238 474 586 684 476 498 577 536 564 605 597
CWIP 89 43 39 24 33 18 23 13 31 12 55 11
Investments 2 0 59 428 428 239 180 171 83 38 0 4
268 342 336 485 751 599 677 693 737 821 856 929
Total Assets 586 623 908 1,523 1,896 1,332 1,378 1,454 1,386 1,435 1,517 1,540

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
-4 -45 -24 -0 -7 45 116 115 115 31 17 31
-55 -81 -157 -310 -116 7 -68 -72 10 -94 -65 -6
35 146 179 309 147 -57 -20 -43 -139 67 32 -1
Net Cash Flow -24 20 -1 -2 24 -5 28 0 -14 4 -16 23

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 73 77 95 116 136 111 98 99 93 85 88 89
Inventory Days 173 175 153 164 165 125 134 132 139 160 152 166
Days Payable 306 198 147 175 208 127 141 133 119 119 107 125
Cash Conversion Cycle -59 54 101 105 93 110 92 98 112 126 132 131
Working Capital Days 5 47 57 99 79 86 77 74 88 106 115 118
ROCE % -10% -4% 9% 2% 1% 40% 9% 12% 16% 6% -3%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
53.86% 53.52% 53.02% 53.02% 52.79% 52.79% 52.79% 52.79% 52.79% 52.79% 52.79% 52.79%
13.60% 14.12% 6.42% 5.84% 6.45% 6.57% 6.25% 5.89% 6.27% 6.03% 6.12% 6.16%
2.49% 2.03% 2.13% 2.04% 2.27% 2.79% 2.81% 2.92% 2.92% 3.23% 7.23% 7.59%
29.46% 29.73% 37.89% 38.60% 38.10% 37.48% 37.76% 38.00% 37.64% 37.57% 33.69% 33.29%
0.60% 0.60% 0.54% 0.51% 0.39% 0.39% 0.39% 0.39% 0.39% 0.39% 0.17% 0.17%
No. of Shareholders 86,8481,24,0141,67,8121,91,0921,97,1761,93,9541,96,2311,91,8751,87,4741,84,5211,72,8531,66,593

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls